Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1029-1037

  Yajima, Satoshi ^a,b   Ishii, Mie ^c   Matsushita, Hisayuki ^d   Aoyagi, Kazuhiko ^a   Yoshimatsu, Kazuhiko ^e   Kaneko, Hironori ^b   Yamamoto, Nobuko ^c   Teramoto, Tatsuo ^b   Yoshida, Teruhiko ^a   Matsumura, Yasuhiro ^d   Sasaki, Hiroki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CANON INC   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Colonocyte; Colorectal cancer screening; Expression profiling; Microarray

Indexed keywords

ARTICLE; COLON; COLORECTAL TUMOR; CYTOLOGY; DNA MICROARRAY; FECES; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INTESTINE CELL; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; COLON; COLORECTAL NEOPLASMS; ENTEROCYTES; FECES; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 38449116710     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schman LM and Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371, 1993.
2. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD and Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477, 1996.
3. Kronborg O, Fenger C, Olson J, Jorgensen OD and Sondergaard O: Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471, 1996.
4. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D and Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317: 559-565, 1998.
5. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S and Simmang C: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124: 544-560, 2003. (Pubitemid 36169269)
6. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC and Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607, 2000.
7. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P and Vogelstein B: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
8. Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M, Fujii A, Ohta H, Nakajima T, Okuda M, Baba S, et al: Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA). Oncogene 10: 1441-1445, 1995.
9. Smith-Ravin J, England J, Talbot IC and Bodmer W: Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 36: 81-86, 1995.
10. Eguchi S, Kohara N, Komuta K and Kanematsu T: Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 77: 1707-1710, 1996.
11. Nollau P, Moser C, Weinland G and Wagener C: Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66: 332-336, 1996.
12. Ratto C, Flamini G, Sofo L, Nusera P, Ippliti M, Curigliano G, Ferreti G, Sgambato A, Merico M, Doglietto GB, Cittadini A and Crucitti F: Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces. Dis Colon Rectum 39: 1238-1244, 1996.
13. Deuter R and Muller O: Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Hum Mutat 11: 84-89, 1998.
14. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN and Shuber AP: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219-1227, 2000.
15. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D'Allessio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuber A, Kinzler KW, Vogelstein B and Jen J: Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 93: 858-865, 2001.
16. Rengucci C, Maiolo P, Saragoni L, Zoli W, Amadori D and Calistri D: Multiple detection of genetic alterations in tumors and stool. Clin Cancer Res 7: 590-593, 2001. (Pubitemid 32707983)
17. Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW and Vogelstein B: Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 359: 403-404, 2002.
18. Traverso G, Shuber A, Levin B, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW and Vogelstein B: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311-320, 2002.
19. Boynton KA, Summerhayes IC, Ahlquist DA and Shuber AP: DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 49: 1058-1065, 2003.
20. Matsumura Y and Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992.
21. Mastumura Y, Hanbury D, Smith J and Tarin D: Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 308: 619-624, 1994.
22. Yamao T, Matsumura Y, Shimada Y, Moriya Y, Sugihara K, Akasu T, Fujita S and Kakizoe T: Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology 114: 1196-1205, 1998. (Pubitemid 28243905)
23. Matsushita H, Matsumura Y, Moriya Y, Akasu T, Fujita S, Yamamoto S, Onouchi S, Saito N, Sugito M, Ito M, Kozu T, Minowa T, Nomura S, Tsunoda H and Kakizoe T: A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology 129: 1918-1927, 2005.
24. Mori K, Aoyagi K, Ueda T, Danjoh I, Tsubosa Y, Yanagihara K, Matsuno Y, Sasako M, Sakamoto H, Mafune K, Kaminishi M, Yoshida T, Terada M and Sasaki H: Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 313: 931-937, 2004.
25. Okamoto T, Suzuki T and Yamamoto N: Microarray fabrication with covalent attachment of DNA using Bubble Jet Technology. Nat Biotech 18: 438-441, 2000.
26. Mori K, Suzuki T, Uozaki H, Nakanishi H, Ueda T, Matsuno Y, Kodera Y, Sakamoto H, Yamamoto N, Sasako M, Kaminishi M and Sasaki H: Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications. Ann Surg Oncol 14: 1694-1702, 2007.